Path 2

AB Leadership News Press Releases Cecile Richards Thursday, Jun 13 2024

AB21 Co-Chair Cecile Richards on SCOTUS Decision on Mifepristone Case

Jun 13, 2024

Today, the U.S. Supreme Court announced their decision that they unanimously rejected a challenge to mifepristone — the FDA-approved abortion pill.

In response, American Bridge 21st Century Co-Chair Cecile Richards released the follow statement:

“Today the Supreme Court unanimously rejected a baseless attack on medication abortion from anti-abortion activists.

Pregnant people and doctors all over the country are breathing a sigh of relief to know that the Court has not ruled to end access to this FDA-approved medication, which has been safely and effectively used for more than 20 years for abortion care and miscarriage treatment.

The Court never should have taken this case in the first place. This was an attempt at a backdoor abortion ban – a calculated effort to dramatically disrupt access to the most common form of abortion in the United States. It was based on junk science and a transparent political agenda.

The Court didn’t rule out future challenges to mifepristone. And right now, we’re seeing attacks on medication abortion at the state level – like in Louisiana, which recently became the first state in the country to define the two drugs used in medication abortion as dangerous controlled substances and criminalize their possession.

The only surefire way to protect access to this evidence-based medical care women depend on is to elect Joe Biden and Kamala Harris in November – and double down on our efforts to repair the damage Donald Trump and this court caused by overturning Roe in states all across this country.”


Published: Jun 13, 2024 | Last Modified: Jun 21, 2024

Jump to Content